For the best experience on the Abcam website please upgrade to a modern browser such as Google Chrome
Publishing research using ab124918? Please let us know so that we can cite the reference in this datasheet.
ab124918 has been referenced in 3 publications.
- Hollingworth R et al. Activation of DNA Damage Response Pathways during Lytic Replication of KSHV. Viruses 7:2908-27 (2015).
- Sowd GA et al. SV40 utilizes ATM kinase activity to prevent non-homologous end joining of broken viral DNA replication products. PLoS Pathog 10:e1004536 (2014).
- Juvekar A et al. Combining a PI3K inhibitor with a PARP inhibitor provides an effective therapy for BRCA1-related breast cancer. Cancer Discov 2:1048-63 (2012).
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"